SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-049930
Filing Date
2022-09-14
Accepted
2022-09-14 16:40:36
Documents
2
Period of Report
2022-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1693
2 POA DOCUMENT poa.txt EX-24 3844
  Complete submission text file 0001209191-22-049930.txt   7057
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Maynard Ryan D (Reporting) CIK: 0001363984 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36279 | Film No.: 221243447